N4P.L Stock: N4 Pharma Plc Stock Price, Analysis & Insights
Get live N4P.L stock price $0.47, comprehensive N4 Pharma Plc stock analysis, charts, news, and expert forecast. Real-time N4P.L stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
N4 Pharma Plc is a specialized pharmaceutical company dedicated to creating advanced silica nanoparticle delivery platforms for pharmaceutical and biotechnology organizations throughout the United Kingdom. A core product is Nuvec, a non-viral adjuvan...
Company Information
- CEO
- David Horn Solomon
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 5
Contact Information
- Website
- https://www.n4pharma.com
- Address
- 60 Gracechurch Street
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: 0.29) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for N4 Pharma Plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for N4 Pharma Plc
- ⚠Investors should consider how N4 Pharma Plc fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
3.95M
P/E Ratio (TTM)
-0.47
Beta
0.29
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare N4P.L with peer companies:
- Price
- $3.00+0.00% (1D)
- Market cap
- 1.57M
- Price
- $10.50+0.00% (1D)
- Market cap
- 407.17M
- Price
- $7.65+0.00% (1D)
- Market cap
- 335.18M
- Price
- $1.24+5.53% (1D)
- Market cap
- 727.88M
- Price
- $8.75+0.00% (1D)
- Market cap
- 455.31M
- Price
- $0.18+0.28% (1D)
- Market cap
- 384.56M
- Price
- $1.55+0.00% (1D)
- Market cap
- 447.83M
- Price
- $0.46-3.05% (1D)
- Market cap
- 429.56M
- Price
- $0.24+0.00% (1D)
- Market cap
- 515.75M
- Price
- $7.25+0.00% (1D)
- Market cap
- 516.45M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
51/100 ⭐⭐⭐
- Overall
- -0.9%
- NYSE
- -1.2%
- NASDAQ
- -0.6%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.2% | +1.1% | +1.8% | 19.8 | 86/100⭐⭐⭐⭐⭐ |
| Technology | +0.6% | +0.9% | +2.8% | 51.6 | 76/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.5% | -0.0% | +1.6% | 27.8 | 65/100⭐⭐⭐⭐ |
| Industrials | -0.5% | -1.2% | +2.5% | 42.9 | 60/100⭐⭐⭐⭐ |
| Communication Services | -0.5% | -1.0% | +0.7% | 21.9 | 52/100⭐⭐⭐ |
| Healthcare | -0.9% | -1.9% | +1.6% | 30.5 | 51/100⭐⭐⭐ |
| Consumer Defensive | +0.2% | +1.1% | -3.0% | 31.0 | 40/100⭐⭐⭐ |
| Energy | +1.3% | -2.9% | +0.7% | 36.3 | 40/100⭐⭐⭐ |
| Real Estate | +0.3% | -1.3% | -0.2% | 49.9 | 30/100⭐⭐ |
| Utilities | +1.0% | -2.3% | -6.1% | 26.0 | 26/100⭐⭐ |
| Consumer Cyclical | -1.7% | -1.0% | -1.5% | 53.5 | 24/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-12.